Hexadecanesulfonyl fluoride
Star0
Identification
- Generic Name
- Hexadecanesulfonyl fluoride
- DrugBank Accession Number
- DB02035
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 308.495
Monoisotopic: 308.218529195 - Chemical Formula
- C16H33FO2S
- Synonyms
- 1-Hexadecanesulfonyl fluoride
- Hexadecane-1-sulfonyl fluoride
- External IDs
- AM 374
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UPalmitoyl-protein thioesterase 1 Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as sulfonyl fluorides. These are compounds containing a sulfonyl (R-S(=O)2-R') functional group singly bonded to a fluorine atom.
- Kingdom
- Organic compounds
- Super Class
- Organohalogen compounds
- Class
- Sulfonyl halides
- Sub Class
- Sulfonyl fluorides
- Direct Parent
- Sulfonyl fluorides
- Alternative Parents
- Sulfonyls / Organosulfonic acids and derivatives / Organic oxides / Hydrocarbon derivatives
- Substituents
- Aliphatic acyclic compound / Hydrocarbon derivative / Organic oxide / Organic oxygen compound / Organic sulfonic acid or derivatives / Organosulfonic acid or derivatives / Organosulfur compound / Sulfonyl / Sulfonyl fluoride
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- acyl fluoride (CHEBI:43275)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- ANCAJYD3FV
- CAS number
- 86855-26-7
- InChI Key
- QIVFMUVBIHIZAM-UHFFFAOYSA-N
- InChI
- InChI=1S/C16H33FO2S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20(17,18)19/h2-16H2,1H3
- IUPAC Name
- hexadecane-1-sulfonyl fluoride
- SMILES
- CCCCCCCCCCCCCCCCS(F)(=O)=O
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.000316 mg/mL ALOGPS logP 7.07 ALOGPS logP 6.33 Chemaxon logS -6 ALOGPS Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 34.14 Å2 Chemaxon Rotatable Bond Count 15 Chemaxon Refractivity 84.68 m3·mol-1 Chemaxon Polarizability 38.22 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier + 0.983 Caco-2 permeable - 0.5503 P-glycoprotein substrate Non-substrate 0.7975 P-glycoprotein inhibitor I Non-inhibitor 0.7342 P-glycoprotein inhibitor II Non-inhibitor 0.9785 Renal organic cation transporter Non-inhibitor 0.9081 CYP450 2C9 substrate Non-substrate 0.8051 CYP450 2D6 substrate Non-substrate 0.8123 CYP450 3A4 substrate Non-substrate 0.5822 CYP450 1A2 substrate Non-inhibitor 0.6378 CYP450 2C9 inhibitor Non-inhibitor 0.8077 CYP450 2D6 inhibitor Non-inhibitor 0.8661 CYP450 2C19 inhibitor Non-inhibitor 0.6997 CYP450 3A4 inhibitor Non-inhibitor 0.9454 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8671 Ames test Non AMES toxic 0.6082 Carcinogenicity Carcinogens 0.6401 Biodegradation Ready biodegradable 0.643 Rat acute toxicity 3.0519 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.7353 hERG inhibition (predictor II) Non-inhibitor 0.6413
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-00c0-3920000000-5a2774667bea89cd1646 Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0a4i-7439000000-bbc18b99b5bf0c99f688 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0a4i-0009000000-69b0cff7bd0e4d9b00ac Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-0a4i-0009000000-aadc5762087993741098 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0a4j-8910000000-ec10acc7e9425dc8dd7b Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-01q9-9620000000-3ffc8e2c372dbbc9f1a6 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0536-9000000000-ae4c102eabe1a0ccd661 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 176.03104 predictedDeepCCS 1.0 (2019) [M+H]+ 180.0507 predictedDeepCCS 1.0 (2019) [M+Na]+ 189.2407 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsPalmitoyl-protein thioesterase 1
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Palmitoyl-coa hydrolase activity
- Specific Function
- Removes thioester-linked fatty acyl groups such as palmitate from modified cysteine residues in proteins or peptides during lysosomal degradation. Prefers acyl chain lengths of 14 to 18 carbons.
- Gene Name
- PPT1
- Uniprot ID
- P50897
- Uniprot Name
- Palmitoyl-protein thioesterase 1
- Molecular Weight
- 34193.245 Da
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52